Abbonarsi

Neurological syndrome with acute dysesthesia and confusion during epidural anesthesia for a caesarian section. Blood concentrations of local anesthetics were considered non-toxic - 07/05/15

Doi : 10.1016/j.toxac.2015.03.071 
A. Coquerel 1, 2, 4, , M. Loilier 1, F. Girard 3, J. Bourgine 1, 4, M. Sassier 2, S. Fedrizzi 2, J. Alexandre 2, 5
1 Laboratory of Pharmacology-Toxicology 
2 Pharmacovigilance Regional Center 
3 Department of Anesthesia, University Hospital, Caen 
4 Inserm U1075, University of Caen 
5 Cardiologic Research Team EA4650, University of Caen 

Corresponding author.

Riassunto

Introduction

Overdoses of local anesthetics (LA) are well-known to induce neurological or cardiologic symptoms such as convulsions, confusion, cardiac arrhythmia and cardiac failure. In most cases, LA diffuse out of a catheter used for loco-regional administration into the bloodstream. Severe side effets are observed when blood concentrations reach toxic levels. We report a case of neurological syndrome after epidural administration of lidocaine and ropivacaine at usual doses for a caesarian section. The symptoms fortunately resolved. A few minutes after the beginning of the incident, a blood sample was taken to assay the LA levels.

Case

The patient was a 37-year-old woman, primipara, with a history of Crohn's disease and endometriosis. The pregnancy was normal, bit the decision to perform a ceasarian section was made after an episode of fetal bradycardia. Regional anesthesia on D1 at 5:45 pm, with epidural LA: ropivacaine 0.2%, 10mL and lidocaine 2%, 15mL. The procedure took place normally without evidence of extravasation. The child was born with normal behavior (Apgar score 10/10 at 1 and 5min). after the birth, the mother complained of dysarthria, dusfunction of taste and labial dysesthesia. The, she exhibited dizziness and e few upper limb clonic seizures, immediately followed by relative agitation without loss of consciousness. A blood sanple was taken just before the injection of Intralipid® (soybena oil) and analyzed by GC-MS.

Results

Serum lidocaine concentration was 1.5mg/L and ropivacaine 0.10mg/L. The lidocaine concentration range considered as non-toxic in cardiology is 1.5–6mg/L. Intralipid® perfusion accelerated the rapid regression of symptoms. No other cardiac or vascular sign was reported. An MRI was done, which was normal and ruled out a stroke.

Discussion

The elimination half-life (T1/2e) of lidocaine (α=0.5h; ß=1–2h) and ropivacaine (1.8h) could not explain higher blood concentrations at the time of surgery. Reported toxic blood concentrations for lidocaine are>6mg/L. Unfortunately, we did not assay the LA-fractions. There was non-associated medication, including sedatives, morphinomimetics, antibiotics and NSAIDS that could have increased the LA-free fraction after IV injection. Other authors found various cases of LA side effects with the usual dosage and in the absence of extravasation [1]. The LA levels were also within the therapeutic range [2].

Conclusion

The acute neurological side effects induced by LA could occur at the therapeutic dosage, with blood concentrations within the usual therapeutic values.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2015  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 27 - N° 2S

P. S48 - Giugno 2015 Ritorno al numero
Articolo precedente Articolo precedente
  • Alcool ou alcools ? Quand l’analyse devient une urgence…
  • M. Meharon, G. Carsenac, P. Bernadet, A. Courtois, M. Labadie
| Articolo seguente Articolo seguente
  • Syndrome confusionnel chez une fille de 4 ans : intoxication rare par Sarcococca confusa
  • G. Evrard, L. Grandgeorge, N. Castaing, A. Badoc, M. Labadie

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.